Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care

被引:108
作者
Allen, ML
Peters, MJ
Goldman, A
Elliott, M
James, I
Callard, R
Klein, NJ
机构
[1] Inst Child Hlth, Immunobiol Unit, London, England
[2] Inst Child Hlth, Portex Dept Anaesthesia Intens Therapy & Resp Med, London, England
[3] Great Ormond St Hosp Children NHS Trust, Cardiac Intens Care Unit, London WC1N 3JH, England
关键词
monocyte human lymphocyte antigen-DR; major histocompatibility complex class II; pediatric cardiac surgery; sepsis; inflammation; systemic inflammation; multiple organ failure; prediction; pediatric; critical illness;
D O I
10.1097/00003246-200205000-00031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Sepsis and systemic inflammatory response syndrome (SIRS) are major causes of morbidity and mortality after cardiopulmonary bypass. Attempts to suppress proinflammatory mediators have failed to improve outcomes in sepsis or in patients undergoing cardiopulmonary bypass. Recent work in adult patients has suggested that the balance between pro- and anti-inflammatory mediators is more important than the level of proinflammatory response alone. This balance may be reflected by the expression of monocyte human lymphocyte antigen (HLA)-DR, with low concentrations indicating an excess of anti-inflammatory stimuli and relative immunodeficiency. We investigated the relationship between monocyte HLA-DR expression and the subsequent development of sepsis/SIRS in children undergoing cardiopulmonary bypass. Design: A prospective, observational, clinical study. Setting: A tertiary pediatric cardiac center. Patients: Eighty-two infants and children undergoing elective cardiac surgery between March and December 1999. Measurements and Main Results: Monocyte HLA-DR expression was assessed before and after surgery and was found to be related to the length of hospital stay and the development of complications including sepsis/SIRS. The inflammatory insult of cardiopulmonary bypass decreased monocyte HLA-DR expression in all children. Lowest concentrations were seen within 72 hrs of surgery and were significantly lower in cases that subsequently required prolonged intensive care support (p < .0001, Mann-Whitney). HLA-DR expression on <60% of circulating monocytes was associated with a greatly increased risk of later (minimum 4 days) development of sepsis/SIRS (odds ratio, 12.9; 95% confidence interval, 3.4-47.5). Low HLA-DR was an independent predictor for the development of sepsis/SIRS after correction for age, bypass time, complexity of surgery, Paediatric Index of Mortality, and surgeon on multiple logistic regression analysis. Conclusions: Patients with decreased HLA-DR in the early postoperative period represent a subpopulation at greatly increased risk of later sepsis/SIRS. Such patients may benefit from strategies aimed to reduce this risk.
引用
收藏
页码:1140 / 1145
页数:6
相关论文
共 33 条
[1]   The inflammatory balance in human sepsis [J].
Adrie, C ;
Pinsky, MR .
INTENSIVE CARE MEDICINE, 2000, 26 (04) :364-375
[2]  
[Anonymous], INTENS CARE MED
[3]   Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis [J].
Astiz, M ;
Saha, D ;
Lustbader, D ;
Lin, R ;
Rackow, E .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (06) :594-600
[4]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[5]   SEPSIS AND CONTROLLED CLINICAL-TRIALS - THE ODYSSEY CONTINUES [J].
BONE, RC .
CRITICAL CARE MEDICINE, 1995, 23 (08) :1313-1315
[6]   Sir Isaac Newton, sepsis, SIRS, and CARS [J].
Bone, RC .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1125-1128
[7]   HLA-DR ANTIGEN EXPRESSION ON PERIPHERAL-BLOOD MONOCYTES CORRELATES WITH SURGICAL INFECTION [J].
CHEADLE, WG ;
HERSHMAN, MJ ;
WELLHAUSEN, SR ;
POLK, HC .
AMERICAN JOURNAL OF SURGERY, 1991, 161 (06) :639-645
[8]   CORTICOSTEROID TREATMENT FOR SEPSIS - A CRITICAL-APPRAISAL AND METAANALYSIS OF THE LITERATURE [J].
CRONIN, L ;
COOK, DJ ;
CARLET, J ;
HEYLAND, DK ;
KING, D ;
LANSANG, MAD ;
FISHER, CJ .
CRITICAL CARE MEDICINE, 1995, 23 (08) :1430-1439
[9]   HLA-DR expression and soluble HLA-DR levels in septic patients after trauma [J].
Ditschkowski, M ;
Kreuzfelder, E ;
Rebmann, V ;
Ferencik, S ;
Majetschak, M ;
Schmid, EN ;
Obertacke, U ;
Hirche, H ;
Schade, UF ;
Grosse-Wilde, H .
ANNALS OF SURGERY, 1999, 229 (02) :246-254
[10]   Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment [J].
Docke, WD ;
Randow, F ;
Syrbe, U ;
Krausch, D ;
Asadullah, K ;
Reinke, P ;
VolK, HD ;
Kox, W .
NATURE MEDICINE, 1997, 3 (06) :678-681